Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC)

World Journal of Urology
Jean Carlo F DatovoLeonardo O Reis

Abstract

To evaluate the underexplored context of cystoscopy adherent versus non-adherent patients in the follow-up of urothelial high-risk non-muscle-invasive bladder cancer (NMIBC). We performed a retrospective study (2005-2016) that evaluated patients´ demographical characteristics, histopathological data, recurrence, progression and cancer-specific mortality between adherent and non-adherents patients in the first 3 years of a proposed cystoscopy protocol. Among the 198 included patients, comparing cystoscopy non-adherent (n = 36, 18%) and adherent patients (n = 162, 82%), there was no demographic or histopathological differences; the rates of disease recurrence, progression and cancer-specific mortality were 15 (41.7%) versus 68 (42.2%), p = 0.58; 12 (33.3%) versus 28 (17.9%), p = 0.014 and 4 (11.1%) versus 19 (11.7%), p = 0.98, respectively. Cystoscopy non-adherence was associated with an inferior number of urinary cytology (p < 0.001) and 2.33 HR for cancer progression, p = 0.014, (95% CI 1.18-4.59). Non-adherence to follow-up cystoscopy in NMIBC is associated with more than twice progression risk. Future studies are needed to confirm our results and correlate cystoscopy non-adherence to other covariates.

References

Apr 17, 2003·Journal of the National Cancer Institute·Deborah SchragColin B Begg
Nov 22, 2007·World Journal of Urology·Yair LotanNúria Malats
Jun 21, 2011·European Urology·Derya TilkiAlexandre R Zlotta
Apr 18, 2012·ANZ Journal of Surgery·Mark T SiddinsLisa Jane Bamberg
Oct 23, 2012·European Urology·Ashish M KamatUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
May 3, 2016·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Leonardo Oliveira ReisMarcos Vinicius Sadi
Jun 19, 2016·The Journal of Urology·Sam S ChangJames M McKiernan
Jun 22, 2016·European Urology·Marko BabjukRichard Zigeuner
Jul 3, 2016·European Urology·Sebastien AntoniFreddie Bray
Jul 5, 2016·Bladder Cancer·Nicholas E Power, Jonathan Izawa
Sep 1, 2016·Nature Reviews. Urology·Bas W G van Rhijn, Maximilian Burger
Nov 17, 2016·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M RouprêtA Méjean
Jan 7, 2017·BJU International·Solomon L WolduYair Lotan

❮ Previous
Next ❯

Citations

Mar 12, 2020·International Urology and Nephrology·Danilo Leite AndradeLeonardo Oliveira Reis
Aug 3, 2019·World Journal of Urology·Leonardo O Reis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revue de l'infirmière et de l'assistante sociale
The Australasian Nurses Journal
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
C Coulange
© 2022 Meta ULC. All rights reserved